SOPH241220P2500
- 0.05
- 0.000.00%
Sophia Genetics Newsroom
SOPHiA GENETICS Announced The Global Launch Of MSK-impact Powered With Sophia DDM From The Association For Molecular Pathology Annual Meeting
Morgan Stanley Maintains Sophia Genetics(SOPH.US) With Hold Rating, Maintains Target Price $5
Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)
Earnings Call: SOPHiA GENETICS Reported A16% Year-over-year Increase in Analysis Volume
Sophia Genetics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss on Tuesday.
SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript Summary
SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript
SOPHiA GENETICS: Strong Buy Rating Amidst Promising Growth Prospects and Financial Stability
TD Cowen Maintains Sophia Genetics(SOPH.US) With Buy Rating
Sophia Genetics Hires George Cardoza as CFO
SOPHiA GENETICS Faces Financial Challenges Amid Losses
Sophia Genetics | 6-K: Report of foreign private issuer (related to financial reporting)
Sophia Genetics Q3 2024 GAAP EPS $(0.28) Misses $(0.22) Estimate, Sales $15.853M Beat $15.850M Estimate
Earnings Flash (SOPH) SOPHIA GENETICS Posts Q3 Revenue $15.9M
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
Press Release: SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
SOPHiA GENETICS Promotes Ross Muken To President And Appoints George Cardoza As Chief Financial Officer >SOPH
SOPHiA GENETICS Backs 2024 Rev $65M-$67M >SOPH
SOPHiA GENETICS 3Q Loss/Shr 28c >SOPH
Exploring Sophia Genetics's Earnings Expectations